1q Gain, a Prognostic Biomarker in Nephroblastoma, and What's Next?
Journal of Clinical Oncology (JCO) Podcast · Birgit Geoerger
July 11, 20169m 2s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This podcast comments on two independent pediatric studies on both sides of the Atlantic showing the relevance of 1q gain in poor prognosis Wilms tumors which raises the perspectives for therapeutic modifications.